AU2002337268A1 - Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorder - Google Patents

Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorder

Info

Publication number
AU2002337268A1
AU2002337268A1 AU2002337268A AU2002337268A AU2002337268A1 AU 2002337268 A1 AU2002337268 A1 AU 2002337268A1 AU 2002337268 A AU2002337268 A AU 2002337268A AU 2002337268 A AU2002337268 A AU 2002337268A AU 2002337268 A1 AU2002337268 A1 AU 2002337268A1
Authority
AU
Australia
Prior art keywords
treatment
stromal tissue
tissue disorder
vaccine use
illnesses associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002337268A
Other versions
AU2002337268B2 (en
Inventor
Bernard Bizzini
Helene Le Buanec
Daniel Zagury
Jean Francois Zagury
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neovacs SA
Original Assignee
Neovacs SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0110751A external-priority patent/FR2828404B1/en
Application filed by Neovacs SA filed Critical Neovacs SA
Publication of AU2002337268A1 publication Critical patent/AU2002337268A1/en
Application granted granted Critical
Publication of AU2002337268B2 publication Critical patent/AU2002337268B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002337268A 2001-08-10 2002-08-09 Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorder Ceased AU2002337268B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR01/10751 2001-08-10
FR0110751A FR2828404B1 (en) 2001-08-10 2001-08-10 COMPOSITE SUPERIMMUNOGEN FOR BIFUNCTIONAL VACCINE USE FOR THE TREATMENT OF DISEASES ASSOCIATED WITH STROMAL TISSUE DISORDER
PCT/FR2002/002853 WO2003013593A2 (en) 2001-08-10 2002-08-09 Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorder

Publications (2)

Publication Number Publication Date
AU2002337268A1 true AU2002337268A1 (en) 2003-06-19
AU2002337268B2 AU2002337268B2 (en) 2007-02-01

Family

ID=8866487

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002337268A Ceased AU2002337268B2 (en) 2001-08-10 2002-08-09 Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorder

Country Status (12)

Country Link
US (1) US20040185058A1 (en)
EP (1) EP1427441B1 (en)
JP (1) JP2005502647A (en)
CN (1) CN1568197A (en)
AT (1) ATE489966T1 (en)
AU (1) AU2002337268B2 (en)
CA (1) CA2456802A1 (en)
DE (1) DE60238492D1 (en)
DK (1) DK1427441T3 (en)
ES (1) ES2355711T3 (en)
FR (1) FR2828404B1 (en)
WO (1) WO2003013593A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5061099B2 (en) * 2005-05-24 2012-10-31 ネオヴァク Method for producing a stable immunogenic product comprising an antigenic heterocomplex of TNFα and a carrier protein
AR078601A1 (en) 2009-06-22 2011-11-23 Wyeth Llc STAPHYLOCOCCUS AUREUS IMMUNOGENIC ANTIGENS COMPOSITIONS
ES2729934T3 (en) 2009-06-22 2019-11-07 Wyeth Llc Compositions and procedures for preparing immunogenic compositions of Staphylococcus aureus serotype 8 capsular polysaccharide conjugate
CN105327350A (en) * 2014-07-23 2016-02-17 中国科学院上海巴斯德研究所 Application of ubiquitin pathway related factor in regulating function of helper T cells
WO2024121424A1 (en) 2022-12-09 2024-06-13 Daniel Zagury Composite aids vaccine generating anti-hiv specific neutralizing antibodies and/or anti-hiv cytotoxic t cells

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2677654B1 (en) * 1991-06-17 1995-11-17 Pasteur Merieux Serums Vacc COMPOUNDS WITH AN IMMUNOGENIC ANTI-CYTOKIN EFFECT, AN ANTIYTOSTATIC IMMUNOGENIC EFFECT OR AN ANTI-HIV INFECTION VACCINE EFFECT.
EP0812358A1 (en) * 1995-02-24 1997-12-17 Cantab Pharmaceuticals Research Limited Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation
CA2215483C (en) * 1995-03-08 2012-01-03 Jean-Francois Zagury Non-toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing same
US5965532A (en) * 1996-06-28 1999-10-12 Trustees Of Tufts College Multivalent compounds for crosslinking receptors and uses thereof
FR2773156B1 (en) * 1997-12-26 2000-03-31 Biovacs Inc NOVEL ANTI-RETROVIRAL IMMUNOGENS (TOXOIDS), NOVEL PREPARATION METHODS AND APPLICATION TO AIDS PREVENTION AND TREATMENT
FR2781158B1 (en) * 1998-07-15 2002-12-13 Vacs Internat NOVEL MODIFIED NON-IMMUNOSUPPRESSIVE IMMUNOGENIC PROTEINS, THEIR PREPARATION PROCESS AND THEIR APPLICATIONS
ES2258869T3 (en) * 1998-10-21 2006-09-01 The United States Government As Represented By The Department Of Health And Human Services VIRUS SIMILAR PARTICLES FOR THE INDUCTION OF AUTO ANTIBODIES.
AU5617900A (en) * 1999-06-17 2001-01-09 Robert C. Gallo Chimeric chemokine-antigen polypeptides and uses therefor
FR2802426B1 (en) * 1999-12-15 2004-04-02 Neovacs USE OF IMMUNOSUPPRESSIVE AND / OR ANGIOGENIC IMMUNOGENIC PROTEINS MADE INACTIVE FOR THE PRODUCTION OF SECRETORY IGAs
EA200200724A1 (en) * 2000-01-31 2003-02-27 Смитклайн Бичем Байолоджикалз С.А. VACCINE FOR PREVENTION OR THERAPEUTIC IMMUNIZATION AGAINST THE VIRUS OF HUMAN IMMUNODEFICIENCY (HIV)
FR2812813B1 (en) * 2000-08-09 2004-11-26 Neovacs USE OF IMMUNOGENS TO TREAT OR PREVENT WITHIN MALIGNANT TUMORS IMMUNE DISORDERS INDUCED BY EXTRACELLULAR FACTORS

Similar Documents

Publication Publication Date Title
IL158107A0 (en) Human papillomaviruses vaccine
AU2002336760A8 (en) Mutable vaccines
AU2002341931A1 (en) Patient directed therapy management
EP1438086A4 (en) Nasal cannula
PT1757606E (en) Xanthinderivatives for use as medical agents and the preparation thereof
AU2002241673A1 (en) Surgical sling delivery system
AU2001251616A1 (en) Remote patient care
AU2002253039A1 (en) Tramadol-based medicament
AU3640399A (en) Respiratory aids
AU2002235175A1 (en) Lometrexol combination therapy
AU2002232432A1 (en) A clamping assembly for maintaining the position of a respiratory care treatment device
AU2002237783A1 (en) Pillows for the physically disabled person
AU2002337268A1 (en) Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorder
ZA200200731B (en) Novel strategy for carbohydrate-based therapeutic vaccines.
AU3978700A (en) Medical use
AU2001278337A1 (en) Respiratory syncytial virus vaccine
AU2001247841A1 (en) Medical procedure
IL151188A0 (en) Medicament for viral diseases
AU2001261552A1 (en) Disposable respirator
AU1043601A (en) Medical use
AU2002309857A1 (en) Vaccines for the treatment of autoimmune disease
AU2002350513A1 (en) Use of solasonine for the treatment of skin tumors
AU2002333499A1 (en) Vaccine against mycobacterial-induced diseases
AU2002248482A1 (en) Disposable blanket
AU2002320410A1 (en) Medical slings